Bayesian post-hoc analysis of chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

J Thorac Cardiovasc Surg. 2022 Sep;164(3):688-693.e1. doi: 10.1016/j.jtcvs.2021.11.056. Epub 2021 Nov 29.

Authors

Nicolas Zhou¹, Kyung Hyun Lee², Claudia Pedroza², Wayne L Hofstetter³

Affiliations

¹ Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex. Electronic address: NZhou@MDAnderson.org.
² Center for Clinical Research and Evidence-Based Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Tex.
³ Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex.

PMID: 34933771
DOI: 10.1016/j.jtcvs.2021.11.056

No abstract available

Keywords: Bayesian; bimodality; chemoradiation; chemotherapy; esophageal; radiation; squamous cell carcinoma; surgery; trimodality.

Publication types

Editorial

MeSH terms

Bayes Theorem
Carcinoma, Squamous Cell* / pathology
Carcinoma, Squamous Cell* / therapy
Chemoradiotherapy
Combined Modality Therapy
Esophageal Neoplasms* / pathology
Esophageal Neoplasms* / therapy
Esophagectomy
Esophagus / pathology
Humans
Neoadjuvant Therapy
Neoplasm Staging